Maarten de Château

Directeur/Membre du Conseil chez XINTELA AB

Profil

Maarten de Château was the founder of Cormorant Pharmaceuticals AB, founded in 2010, where the title held was Chief Executive Officer from 2010 to 2016.
Current jobs include Chief Executive Officer & Director at Sixera Pharma AB since 2017, Chief Executive Officer & Director at Buzzard Pharmaceuticals AB, Chief Executive Officer & Director at Cordivest AB, Chief Executive Officer & Director at MetaCurUm Biotech AB, Director at Beactica Therapeutics AB since 2019, Independent Director at Xintela AB since 2021, Director at Atrogi AB since 2017, Director at Chateau Holding AB, Director at Targinta AB, Director at Cavis Technologies AB, Director at Strike Pharma AB, Director at Amarna Holding BV, Deputy Director at Saare Consulting AB, and Member-Supervisory Board at Amarna Therapeutics BV since 2019.
Former jobs include Director at OxThera AB, Director at AddBIO AB, Director at Gesynta Pharma AB, Deputy Director at Nylof Holding AB, Director at Evident Life Försäkring AB, and Medical Director at Swedish Orphan Biovitrum AB from 2009 to 2013.
Education includes a doctorate from the University of Lund.

Postes actifs de Maarten de Château

Sociétés	Poste	Début
XINTELA AB	Directeur/Membre du Conseil	01/01/2021
Cavis Technologies AB	Directeur/Membre du Conseil	-
Saare Consulting AB	Corporate Officer/Principal	-
Amarna Holding BV	Directeur/Membre du Conseil	-
MetaCurUm Biotech AB	Directeur Général	-
Buzzard Pharmaceuticals AB	Directeur Général	-
Chateau Holding AB	Directeur/Membre du Conseil	-
Cordivest AB	Directeur Général	-
Targinta AB	Directeur/Membre du Conseil	-
░░░░░░ ░░░░░░ ░░	░░░░░░░░░░░░░░░░ ░░ ░░░░░░░	-

Anciens postes connus de Maarten de Château

Sociétés	Poste	Fin
░░░░░░░░░ ░░░░░░░░░░░░░░░ ░░	░░░░░░░░░ ░░░░░░░░░	░░░░░░░░░░
░░░░░░░ ░░░░░░ ░░░░░░░░░ ░░	░░░░░░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░	░░░░░░░░░░
░░░░░░░ ░░░░░░ ░░	░░░░░░░░░░░░░░░░ ░░ ░░░░░░░	-
░░░░░░░ ░░	░░░░░░░░░░░░░░░░ ░░ ░░░░░░░	-
░░░░░░ ░░	░░░░░░░░░░░░░░░░ ░░ ░░░░░░░	-